Therefore, in the cell lines tested, the effects of ENDOG silencing on cell proliferation occurred in tumor cells with the highest p-AKT and low PTEN, except for the U87 GBM cell line, pointing to the existence of additional factors determining the impact of ENDOG on proliferation. The gene discussed is PTEN; the disease is glioblastoma.